BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1687220)

  • 1. HTLV-I p24 antigen in circulating immune complexes associated with acute T-lymphoblastic leukemia.
    Segal-Eiras A; Croce MV
    Haematologica; 1991; 76(5):441-2. PubMed ID: 1687220
    [No Abstract]   [Full Text] [Related]  

  • 2. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay.
    Ebersold A; Noraz N; Grange J; Gasmi M; Grange MP; Souche S; Mamoun R; Desgranges C
    Hybridoma; 1993 Apr; 12(2):185-95. PubMed ID: 7686136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antigenic sites of the envelope glycoprotein of the Iranian isolate of human T-cell leukemia virus type 1 with different subtypes of the virus.
    Mohabatkar H; Sadeghi S
    Saudi Med J; 2006 Aug; 27(8):1121-4. PubMed ID: 16883437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
    Lal RB; Brodine SK; Coligan JE; Roberts CR
    J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies.
    Banki K; Maceda J; Hurley E; Ablonczy E; Mattson DH; Szegedy L; Hung C; Perl A
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1939-43. PubMed ID: 1347429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Random suppression of T cells that bear specific T cell receptor V beta sequences in adult T cell leukemia/lymphoma (ATLL) patients at each clinical stage: carrier, smoldering, chronic, and acute.
    Ohshima K; Suzumiya J; Kikuchi M; Takeshita M; Tashiro K; Kimura N
    Am J Hematol; 1996 May; 52(1):1-7. PubMed ID: 8638605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p24 protein of a human T-lymphotropic virus type-I (HTLV-I) producing cell line (TCL-Kan) reacts with some normal pregnant women's sera.
    Ando Y; Hashimoto H; Kakimoto K; Tanigawa T; Moriyama I; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1251-5. PubMed ID: 2212826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 1st case of adult T-cell leukemia (ATL) with expressed immune response to HTLV in the USSR].
    Gurtsevich VE; Seniuta NB; Pivnik AV; Pavlish OA; Stepina VN; Syrtsev AV; Iakhnina EI; Kremenetskaia AM
    Vopr Onkol; 1991; 37(5):563-8. PubMed ID: 1767511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibility of HTLV-I transmission from wife with ATL to husband.
    Hirai K; Takemori N; Onodera R; Saito N; Takasugi Y; Namiki M
    Int J Hematol; 1992 Jun; 55(3):305-6. PubMed ID: 1353993
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
    Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
    Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/lymphoma.
    Farre L; de Oliveira Mde F; Primo J; Vandamme AM; Van Weyenbergh J; Bittencourt AL
    Clin Infect Dis; 2008 Feb; 46(3):440-2. PubMed ID: 18173359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.